<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

4 min read

Mergers & Acquisitions: Q123 Spine Enabling Tech Market Recap

7/7/23 10:24 AM

Q123Spine Enabling Tech Recap HEADER copyIn addition to product innovation and increasing adoption, the Spine Enabling Technology market is rapidly evolving due to mergers and acquisitions.

The Q123 WW Spine Enabling Tech Market was up +12.6% YoY, according to SmartTRAK Financial Dashboard. Medtronic (MDT) remained the market leader with 54.9% share, followed by Globus Medical (GMED) and other enabling tech competitors like Brainlab and Stryker (SYK). For detailed Q123 revenues and shares by company in the US, EU and ROW, see SmartTRAK Spine Enabling Tech Financial Dashboard*.

Among the many topics covered in detail in SmartTRAK's comprehensive Q123 US Spine Enabling Technology Market Recap* are:

  • Complete Q123 Spine Enabling Tech Market Overview
  • SmartTRAK's Expert Market Analysis and Insights
  • All Companies' News, Revenues, Data, Charts and Market Shares
  • Mergers and Acquisitions Changing the Spine Enabling Technology Landscape
  • New Spine Robots on the Horizon
  • Milestones in Augmented Reality
  • Q123 Regulatory Highlights

In February 2023, GMED announced it entered into a definitive agreement to combine in an all-stock transaction with NuVasive (NUVA). The transaction is expected to close mid-2023 subject to shareholder and regulatory agency approvals, which will make the combined company the ...

Read the entire Q123 Spine Enabling Tech Market Recap, including SmartTRAK's expert analysis, news, data, charts, revenues and shares*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below. Learn More about Subscribing to SmartTRAK


SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.

 

Elise Wolf
Written by Elise Wolf

Elise Wolf has Bachelor’s and Master’s degrees in Bioengineering from Northwestern University and the University of Pittsburgh. After graduation, Elise designed biologically-inspired autonomous robots for the Department of Defense at K2T, a spin-off of Carnegie Mellon University. She also has 15+ years of experience in the medical device industry in product development, marketing and business development in emerging medical device technologies and orthopedics prior to joining BioMedGPS. Elise has worked for BioMedGPS since 2010 as an Analyst covering Orthopedics and is currently the General Manager of SmartTRAK’s Computer-Assisted Surgery business.

  • There are no suggestions because the search field is empty.

Follow Us on Social Media

Recent Articles